Literature DB >> 26974731

Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemia.

Raul D Santos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26974731     DOI： 10.7326/ACPJC-2016-164-6-031

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

Review 1.  Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care.

Authors:  Olivier S Descamps; Uwe Fraass; Ricardo Dent; Winfried März; Ioanna Gouni-Berthold
Journal:  Int J Clin Pract       Date:  2017-07-27       Impact factor: 2.503

2.  PCSK9 inhibitors - from discovery of a single mutation to a groundbreaking therapy of lipid disorders in one decade.

Authors:  Krzysztof Jaworski; Piotr Jankowski; Dariusz A Kosior
Journal:  Arch Med Sci       Date:  2017-01-19       Impact factor: 3.318
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.